Week of April 26, 2021 MMWR Weekly Briefing

This episode discusses seven MMWR COVID-19 reports. The first report provides an update on the Advisory Committee on Immunization Practices recommendations for Johnson & Johnson's Janssen COVID-19 vaccine. The next two reports are about safety monitoring of the Janssen vaccine. Next is a report on an evaluation of the benefits of mRNA COVID-19 vaccines against hospitalization. Two reports detail COVID-19 outbreaks in workplace settings. The last report examines linked clusters of a variant of the virus that causes COVID-19.